Norgine launches sodium thiosulfate injection in Germany

In the randomised Phase III trials, the data showed nearly a 50% decrease in the cisplatin-induced ototoxicity occurrence in subjects who received the treatment with cisplatin and sodium thiosulfate. Credit: National Cancer Institute in Unsplash.